Bovolini A, Garcia J, Andrade MA, Duart JA. Metabolic syndrome pathophysiology and predisposing factors. Int J Sports Med. 2021;42(03):199–214.

Article  PubMed  Google Scholar 

Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, et al. Metabolic syndrome. Nat Rev Dis Primers. 2024;10(1):77. https://doi.org/10.1038/s41572-024-00563-5.

Article  PubMed  Google Scholar 

Aguilar-Salinas CA, Viveros-Ruiz T. Recent advances in managing/understanding the metabolic syndrome. F1000Res. 2019. https://doi.org/10.12688/f1000research.17122.1.

Article  PubMed  PubMed Central  Google Scholar 

Liang X, Or B, Tsoi MF, Cheung CL, Cheung BM. Prevalence of metabolic syndrome in the united States National health and nutrition examination survey (NHANES) 2011–2018. MedRxiv. 2021;2021–04. https://doi.org/10.1093/eurheartj/ehab724.2420.

National Heart, Lung, and Blood Institute (NHLBI). Metabolic syndrome. Access address: metabolic syndrome - what is metabolic syndrome? | NHLBI, NIH. 2025. Access date: 05/02/2025.

Farmanfarma KK, Kaykhaei MA, Adineh HA, Mohammadi M, Dabiri S, Ansari-Moghaddam A. Prevalence of metabolic syndrome in Iran: a meta-analysis of 69 studies. Diabetes Metab Syndr. 2019;13(1):792–9. https://doi.org/10.1016/j.dsx.2018.11.055.

Article  Google Scholar 

Nilsson PM, Tuomilehto J, Rydén L. The metabolic syndrome-what is it and how should it be managed? Eur J Prev Cardiol. 2019;26(2suppl):33–46. https://doi.org/10.1177/2047487319886404.

Article  PubMed  Google Scholar 

Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):786. https://doi.org/10.3390/ijms23020786.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cho Y, Lee SY. Useful biomarkers of metabolic syndrome. Int J Environ Res Public Health. 2022;19(22):15003. https://doi.org/10.3390/ijerph192215003.

Article  PubMed  PubMed Central  Google Scholar 

Hong T, Li JY, Wang YD, Qi XY, Liao ZZ, Bhadel P, et al. High serum Asprosin levels are associated with presence of metabolic syndrome. Int J Endocrinol. 2021;2021(1):6622129. https://doi.org/10.1155/2021/6622129.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jialal I. Chemerin levels in metabolic syndrome: a promising biomarker. Arch Physiol Biochem. 2023;129(5):1009–11. https://doi.org/10.1080/13813455.2021.1912103.

Article  PubMed  CAS  Google Scholar 

Reddy P, Lent-Schochet D, Ramakrishnan N, McLaughlin M, Jialal I. Metabolic syndrome is an inflammatory disorder: a conspiracy between adipose tissue and phagocytes. Clin Chim Acta. 2019;496:35–44. https://doi.org/10.1016/j.cca.2019.06.019.

Article  PubMed  CAS  Google Scholar 

Shabir K, Brown JE, Afzal I, Gharanei S, Weickert MO, Barber TM, et al. Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: comprehensive review of preclinical and clinical evidence. Cytokine Growth Factor Rev. 2021;60:120–32. https://doi.org/10.1016/j.cytogfr.2021.05.002.

Article  PubMed  CAS  Google Scholar 

Helfer G, Wu QF. Chemerin: a multifaceted adipokine involved in metabolic disorders. J Endocrinol. 2018;238(2):R79–94. https://doi.org/10.1530/joe-18-0174.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hanoush N, Fahad SM, Abdulmageed L. Using chemerin and ınflammation markers to predict coronary ar-tery disease in metabolic syndrome patients. Wasit J Pure Sci. 2023;2(4):136–42. https://doi.org/10.31185/wjps.232.

Article  Google Scholar 

Endukuru CK, Gaur GS, Yerrabelli D, Sahoo J, Vairappan B. Role of chemerin as a putative biomarker of cardiovascular risk in metabolic syndrome: a brief review. Int J Clin Exp Physiol. 2020;10. https://doi.org/10.5530/ijcep.2020.7.1.2.

Ahmadabadi F, Nakhaei H, Mogharnasi M, Huang CJ. Aerobic interval training improves irisin and chemerin levels of both liver and visceral adipose tissues and circulating asprosin in rats with metabolic syndrome. Physiol Int. 2021;108(3):383–397. https://doi.org/10.1556/2060.2021.00182

Tan L, Lu X, Danser AJ, Verdonk K. The role of chemerin in metabolic and cardiovascular disease: a literature review of ıts physiology and pathology from a nutritional perspective. Nutrients, 2023;15(13):2878. https://doi.org/10.3390/nu15132878

Yu M, Yang Y, Huang C, Ge L, Xue L, Xiao Z, et al. Chemerin: a functional adipokine in reproductive health and diseases. Biomedicines. 2022;10(8):1910. https://doi.org/10.3390/biomedicines10081910.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao L, Leung LL, Morser J. Chemerin forms: their generation and activity. Biomedicines. 2022;10(8):2018. https://doi.org/10.3390/biomedicines10082018.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Buechler C, Feder S, Haberl EM, Aslanidis C. Chemerin isoforms and activity in obesity. Int J Mol Sci. 2019;20(5):1128. https://doi.org/10.3390/ijms20051128.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu Y, Liu A, Ye RD. Structural basis for chemerin recognition and signaling through its receptors. Biomedicines. 2024;12(11):2470. https://doi.org/10.3390/biomedicines12112470.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ferland DJ, Mullick AE, Watts SW. Chemerin as a driver of hypertension: a consideration. Am J Hypertens. 2020;33(11):975–86. https://doi.org/10.1093/ajh/hpaa084.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Acewicz M, Kasacka I. Chemerin activity in selected pathological states of human body–a systematic review. Adv Med Sci. 2021;66(2):270–8. https://doi.org/10.1016/j.advms.2021.05.002.

Article  PubMed  CAS  Google Scholar 

Hu S, Shao Z, Zhang C, Chen L, Al Mamun A, Zhao N, et al. Chemerin facilitates intervertebral disc degeneration via TLR4 and CMKLR1 and activation of NF-kB signaling pathway. Aging. 2020;12(12):11732. https://doi.org/10.18632/aging.103339.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lavy M, Gauttier V, Poirier N, Barillé-Nion S, Blanquart C. Specialized pro-resolving mediators mitigate cancer-related inflammation: role of tumor-associated macrophages and therapeutic opportunities. Front Immunol. 2021;12:702785. https://doi.org/10.3389/fimmu.2021.702785.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ye Y, Fang L, Li J, Wu H, Tan X, Luo H, et al. Chemerin/ChemR23 regulates cementoblast function and tooth resorption in mice via inflammatory factors. J Periodontol. 2021;92(10):1470–82. https://doi.org/10.1002/jper.20-0675.

Article  PubMed  CAS  Google Scholar 

Shang J, Wang L, Zhang Y, Zhang S, Ning L, Zhao J, et al. Chemerin/ChemR23 axis promotes inflammation of glomerular endothelial cells in diabetic nephropathy. J Cell Mol Med. 2019;23(5):3417–28. https://doi.org/10.1111/jcmm.14237.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lavy M, Gauttier V, Dumont A, Chocteau F, Deshayes S, Fresquet J, et al. Chemr23 activation reprograms macrophages toward a less inflammatory phenotype and dampens carcinoma progression. Front Immunol. 2023;14:1196731. https://doi.org/10.3389/fimmu.2023.1196731.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Macvanin MT, Rizzo M, Radovanovic J, Sonmez A, Paneni F, Isenovic ER. Role of chemerin in cardiovascular diseases. Biomedicines. 2022;10(11):2970. https://doi.org/10.3390/biomedicines10112970.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schioppa T, Sozio F, Barbazza I, Scutera S, Bosisio D, Sozzani S, et al. Molecular basis for CCRL2 regulation of leukocyte migration. Front Cell Dev Biol. 2020;8:615031. https://doi.org/10.3389/fcell.2020.615031.

Article  PubMed  PubMed Central  Google Scholar